Icecure Medical ICCM is set to give its latest quarterly earnings report on Thursday, 2025-03-27. Here's what investors need to know before the announcement.
Analysts estimate that Icecure Medical will report an earnings per share (EPS) of $-0.07.
Anticipation surrounds Icecure Medical's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Earnings History Snapshot
Last quarter the company missed EPS by $0.00, which was followed by a 5.82% increase in the share price the next day.
Here's a look at Icecure Medical's past performance and the resulting price change:
Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
---|---|---|---|---|
EPS Estimate | -0.08 | -0.07 | -0.08 | -0.07 |
EPS Actual | -0.08 | -0.06 | -0.08 | -0.07 |
Price Change % | 6.0% | -1.0% | -1.0% | 0.0% |
Stock Performance
Shares of Icecure Medical were trading at $1.18 as of March 25. Over the last 52-week period, shares are down 5.0%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Icecure Medical visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.